
Neurointerventional Medical Device Developer
Gelonghui, October 6 |HeartCare-B (06609.HK) issued an announcement stating that the Board proposes the adoption of the 2021 H-Share Incentive Scheme. The 2021 H-Share Incentive Scheme shall take effect subject to consideration and approval by the shareholders at an extraordinary general meeting. The maximum limit of the 2021 H-Share Incentive Scheme shall be the maximum number of H-shares that the trustee may acquire from time to time through on-market purchases at prevailing market prices, which shall in any event not exceed 750,000 H-shares.